Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age
Clinical trial NCT00971542 · COMPLETED
Trial details
- NCT number
- NCT00971542
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-02-01
- Enrollment
- 778
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.